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The clot which forms when oxalated plasma  is recalcified and allowed to 
stand at 37°C. usually dissolves after a variable period of time.  It has been 
pointed  out  elsewhere  (1)  that  this  fibrinolysis  is  particularly  frequent  in 
patients  with  chronic hepatic  disease.  Despite  considerable  recent interest 
in the nature of the proteolytic activity of plasma,  little attention has been 
paid to the mechanism by which clotted human blood dissolves.  The current 
report describes certain phenomena which may contribute to an understanding 
of this mechanism. 
In 1893 Dastre (2) observed that canine fibrin was partially digested when it stood 
in its own serum.  Shortly thereafter, Delezenne and Pozerski (3) showed that serum 
contained a proteolytic enzyme which not only digested fibrin, but gelatin and casein 
as well.  They observed  too that treatment of dog serum with chloroform greatly 
increased  its proteolytic activity, and indeed,  untreated serum actually inhibited 
proteolysis.  Since then, a  large body of evidence has accumulated that the blood 
contains both a proteolytic enzyme system capable of digesting fibrin, and inhibitors 
of this enzyme system.  The manner in which chloroform acts is not deafly under- 
stood, but Delezenne and Pozerski noted that it decreased the inhibitory activity of 
plasma  against  proteolytic enzymes.  It has  been suggested  that  the  proteolytic 
enzymes present in chloroform-treated plasma globulin are then activated spontane- 
ously, perhaps by autocatalysis (4, 5).  As a preliminary hypothesis, then, it might 
be assumed that the rate of fibrinolysis is determined by the relative concentrations 
of enzyme and inhibitor. 
Rapid fibrinolysis  was first described  clinically  by Goodpasture (6),  in patients 
with cirrhosis of the liver.  He noted that the addition of normal plasma to that of a 
patient with atrophic cirrhosis  prevented rapid clot lysis.  For this reason,  Good- 
pasture suggested that rapid fibrinolysis in patients with liver disease was due to a 
decrease  in the concentration of an inhibitor of plasma proteolytic enzyme, rather 
than to an excess of the enzyme itself. 
More recently, Macfarlane and Pilling (7) restudied the mechanism of fibrinolysis. 
A dilute solution of the globulin of plasma precipitated at pH 5.5 promoted clot lysis. 
Hedin (8) had shown  that this fraction exhibited proteolytic activity.  Moreover, 
Macfaflane and Pilling found that the globulin of a patient whose clot lysed rapidly 
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was fibrinolytic  in a concentration one-eighth that of normal globulin.  On the other 
hand, that fraction of normal plasma not precipitated at pH 5.5 inhibited clot lysis. 
This latter fraction, obtained from a  patient whose  clot lysed rapidly, was less in- 
hibitory than that of normal human beings.  Macfarlane and Pilling concluded that 
the spontaneous proteolytic activity observed in their subjects was due to an increase 
in the concentration of plasma proteolytic enzyme and perhaps to a  decrease  in the 
inhibitor of this enzyme as well. 
The mechanism of fibrinolysis has been reinvestigated, taking advantage of 
the  apparent parallel  between  the  fibrinolytic and  caseinolytic activity of 
plasma.  Data will be presented which indicate that the concentration of the 
proteolytic enzymes in plasma did not differ between normal persons and those 
whose plasma clots lysed rapidly.  Furthermore the rate of fibrinolysis could 
not be  related  to  the  ability of  the  patient's plasma  to  inhibit proteolysis. 
However, the inhibitory activity of plasma was unstable and decreased during 
incubation at  37°C.  Evidence  will be  presented  which  indicates  that  the 
speed with which a  clot dissolved was related to  the deterioration of the un- 
stable inhibitory  activity. 
Methods and Materials 
Venous blood was drawn under aseptic conditions from the antecubital vein of human 
subjects and transferred to a 50 cc. centrifuge tube containing 0.2 ce. of oxalate mixture for 
each 5 cc. of blood added (9).  The subjects selected were apparently normal  adults, personnel 
or medical students at the Johns Hopkins Hospital, and patients on the medical and surgical 
wards. 
The rate of fibrinolysis was determined on each plasma.  The clot lysis time was the inter- 
val between the recalcification of plasma and the solution of the resultant clot.  Using the 
necessary technique for sterility, a volume of 0.5 cc. of plasma was pipetted into a Wassermann 
tube and recalcified  with 0.1 cc. of ~/20 calcium chloride.  The number of days which elapsed 
until the dot dissolved was called the clot lysis time.  The sterility of clots which dissolved 
in 2 days or less was confirmed bacteriologically.  A detailed study of the clot lysis time in 
normal and diseased states has been reported separately (1). 
Enzymatic activity was determined by methods previously described (5, 9).  The enzyme- 
substrate  mixture was incubated at 37°C., and the degree of proteolysis was determined by 
assaying the precipitable protein nephelometricaily before and after  digestion.  The sub- 
strate used was a 0.3 per cent solution of casein (vitamin-test, Smaco), dissolved with gentle 
heating in 0.004 N sodium hydroxide.  To measure the precipitable protein, 2 cc. of 12.5 per 
cent hydrochloric acid, and 0.5 ce. of 20 per cent sulfosalicylic  acid were added in rapid suc- 
cession to a 1 cc. aliquot of the solution to be tested.  Maximal turbidity appeared in about 
5 minutes and was read in a cuvette of 10 mm. internal  diameter with a Coleman, Jr., spectro- 
photometer  at a wave length of 420 m~.  With the tube, instrument, and lot of casein used, 
an optical density of 0.225 was equivalent to a concentration of 1.0 rag. of casein per cc. of 
enzyme-substrate mixture.  At a wave length of 420 m~, the degree of turbidity followed 
the Lambert-Beer law to an optical density of approximately 0.550. 
In an earlier publication (5), it was shown that the plasma proteolytic enzymes activated 
by chloroform or by streptococcal fibrinolysin digested casein in direct proportion to the con- 
centration of the enzyme preparation until approximately 0.7 rag. of casein per cc. remained. OSCAR D.  RATNOFF  403 
Beyond this point, digestion was not linear.  For this reason, it was often convenient to 
express the activity of proteolytic enzyme preparations in terms of arbitrary digestion units, 
such that 50 digestion units of enzyme digested 0.50 nag. of casein per cc. of enzyme-substrate 
mixture in 1 hour. 
It should be emphasized that the enzyme and inhibitor fractions prepared in these studies 
were crude and were not purified products or single substances.  A more detailed description 
of the nomenclature and techniques employed has been given in recent publications (1, 5, 9). 
EXPE]~  TM-EI~!TAL 
Tire Relationskip between tke Spontaneous Proteolytic A ctidty of Plasma 
Globulin and the Clot Lysis Time 
In earlier papers  (5,  9),  the  optimal conditions for  the  demonstration of 
proteolytic  activity  in  plasma  globulin were  described.  The  spontaneous 
activity of this preparation was slight.  An attempt was made to  relate the 
TABLE I 
The Spontaneous Proteolytic  Activity of a Plasma Globulin Preparation and tke Clot Lysis Time 
Patient 
Du. 
Co. 
St. 
Fr. 
Clot lysis  time 
days 
1 
2 
5 
6 
Enzymatic  activity 
r~g./cc.* 
0.11 
0.13 
0.13 
0.07 
* Milligrams of casein digested per cubic centimeter  of enzyme-substrate  mixture in 16 
hours. 
rate  of fibrinolysis with  the  spontaneous proteolytic activity of  this plasma 
globulin. 
A 2 cc. portion of sterile plasma was diluted with 38 cc. of water in a round bottomed 
centrifuge tube, and sufficient I per cent acetic acid added to bring the pH to 5.2, as measured 
with a Beckman pH meter.  The precipitate which resulted was separated by centrifugation 
for 15 minutes in an angle centrifuge (rim diameter 10 inches) at 1500 R.P.M., and dissolved 
in 5 cc. of 0.85 per cent sodium chloride solution buffered to pH 7.35 with M/20 potassium 
phosphate  (buffer).  A 2 cc. portion of this globulin solution was then mixed with 2 cc. of 
0.3 per cent casein solution, and the amount of casein digested during a  16 hour period of 
incubation at 37°C. was measured nephelometricaUy.  A few drops of toluol were added as 
a bacteriostatic agent.  The clot lysis time was determined on an aliquot of 0.5 cc. of the 
same plasma. 
The results of one such experiment are  recorded  in Table I.  Plasmas of 
two patients with Laennec's cirrhosis were compared with those of two normal 
adults.  No correlation was noted between the clot lysis time of these subjects 
and the spontaneously developing proteolytic activity O  f a globulin  precipitated 
from the same plasma.  This was also true when the globulin was precipitated 404  PROTEOLYTIC EIqZYME IN HUMAN  PLASMA.  HI 
from  serum  rather  than  plasma.  Furthermore,  the  supematant  solution 
after the precipitation of globulin at pH 5.2 showed no spontaneous proteolytic 
activity. 
The Relationship between Chloroform-Activated Plasma Proteolytic Activity 
and the Clot Lysis Time 
The major portion of the in vitro proteolytic activity of plasma or serum is 
in an inactive state.  Delezenne and Pozerski  (3) observed that treatment of 
serum  with  chloroform  greatly increased  its  proteolytic  activity.  It seemed 
reasonable to suppose that the proteolytic activity of globulin, after treatment 
with  chloroform,  was  a  measure  of  the  total  available  proteolytic  activity. 
Therefore, the relation was studied between the clot lysis time and proteolytic 
activity  which  developed  under  standard  conditions  in  chloroform-treated 
globulin. 
In previous papers (5, 9), certain conditions  were described  for the activation of a pro- 
teolytic enzyme system in plasma globulin.  Briefly, maximal activity was observed when 
the globulin fraction of plasma precipitated at pH 5.2 was dissolved in buffer, mixed with 
chloroform, and incubated for 16 to 22 hours at 37°C. 
The globulin precipitate of 2 cc. of plasma was prepared in the manner described above, 
and dissolved in 0.5 cc. of buffer.  A half cc. portion of chloroform was then added, the cen- 
trifuge tube closed with a rubber stopper, shaken for 10 seconds, and allowed to stand for 
approximately 18 hours in a water bath at 25°C.  The contents of the tube were then trans- 
ferred to a graduated 15 cc. centrifuge  tube, diluted to 5 cc. with buffer, and centrifuged  for 
10 minutes at 2000 R.P.m in the angle centrifuge.  An aliquot of 2 cc. of the supernatant 
solution was then mixed with 2 cc. of 0.3 per cent casein, and incubated at 37°C. for 1 hour 
The proteolysis  of casein  was  measured  by determining  the  protein concentration  of the 
enzyme-substrate  mixture  nephelometrically  before  and  after  incubation.  Enzymatic 
activity was recorded in terms of arbitrary digestion units per cubic centimeter of plasma. 
The chloroform-activated proteolytic activity of the plasma globulin fraction 
of 83 patients with a  wide variety of illnesses including chronic hepatic disease 
was compared with the clot lysis time determined simultaneously on an aliquot 
of the same plasma  (Fig.  I).  No correlation could be demonstrated between 
the  clot lysis time and  the  chloroform-activated plasma proteolytic  activity. 
That is, the rate of fibrinolysis was not related to the proteolytic activity which 
appeared in plasma globulin when it was incubated under standard conditions 
with chloroform. 
The Relationship between Fibrinotysln-Activated  Plasma Proteolytic Activity 
and the Clot Lysis Time 
It has been demonstrated that the fibrinolyfic property of hemolytic strepto- 
coccal fikrates  was due  to the  activation  of a  proteolytic  enzyme present  in 
plasma  globufin  (9-12).  The  probable  identity  of  the  proteotytic  enzymes 
activated  by streptococcal  filtrates  and  by chloroform  was demonstrated  by OSCAR  I). P.AZNO~F  405 
these  authors.  However,  the  proteolytic  enzyme  prepared  by  activating 
plasma globulin with streptococcal filtrates was always more active than that 
prepared  with chloroform  (4,  9).  Therefore,  the possibility that the concen- 
tration  of  this  fibrinolysin-activated enzyme  correlated  with  the  clot  lysis 
time was tested. 
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FIG. 1.  The relationship between clot lysis time and chloroform-activated plasma proteo- 
lytic activity in the globulin fraction of the same plasma in 83 patients. 
The globulin precipitate of 2 cc. of plasma  was prepared in the manner described above 
and dissolved  in 10 cc. of buffer.  An aliquot of 0.5 cc. was  diluted with 1.5 cc. of crude 
streptococcal fibrinolysin,  prepared from the H46A strain of group C beta hemolytic strepto- 
coccus (9).  Briefly,  the filtrate of cultures of the streptococcus in ~ypticase soy broth was 
used as a crude fibrinolysin.  The concentration of fibrinolysin  varied somewhat from hatch 
to hatch.  Each lot was tested to be sure that 1.5 cc. of filtrate was in excess of that amount 
necessary to activate all the available precursor of proteolytic enzyme present in 0.1 cc. of a 
test  plasma.  Approximately  1  minute after  the  streptococcal  fibrinolysin and  globulin 
solutions were mixed, a 2 cc. portion of 0.3 per cent casein solution was added and the protein 
digested during 1 hour at 37°C. was determined nephelometrically. 4O6  PROTEOLYTIC  ENZYME  IN  HUMAN  PLASMA.  HI 
The plasmas of 39 patients with various illnesses including chronic hepatic 
disease  were  studied.  No  relationship  could  be  demonstrated  between  the 
clot lysis time and the streptococcal fibrinolysin-activated plasma proteolytic 
activity (Fig.  2). 
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Fro. 2, The relationship between clot lysis time and streptococcal fibrlnolyshu-activated 
plasma proteolytic activity in the globulin fraction of the same plasma in 39 patients. 
The Relationship between the Ability of Plasma to Inhibit Plasma Proteolytic 
Enzyme and the Clot Lysis Time 
Since rapid fibrinolysis could not be correlated with changes in the available 
proteolytic activity of plasma,  the inhibitory  activity of plasma  against  the 
proteolytic enzyme was investigated. 
To test the inhibitory activity against plasma proteolytic enzyme a measured 
amount  of, plasma  (or  its  fractions)  was  added  to  enzyme.  This  enzyrae- 
inhibitor mixture was then mixed with casein and the amount of casein digested OSCAR D.  ~NO~F  407 
was measured nephelometricaUy.  The enzyme used was a pool of chloroform- 
activated globulin diluted so that it digested approximately 0.50 rag. of casein 
per  cc.  of  enzyme-substrate  mixture  in  2  hours.  This  concentration  was 
chosen so that the amount of casein digested during the 2 hour period would 
be directly proportional to the concentration of enzyme, without further cor- 
rection.  Streptococcal fibrinolysin-activated enzyme was not used since any 
excess fibrinolysin might activate any precursor present in the inhibitor. 
A preliminary study was made to determine the optimal length of time to in- 
cubate inhibitor and enzyme before the addition of substrate. 
In a typical experiment, 1 cc. of plasma was diluted with 29 cc. of buffer.  A 5 cc. portion 
of this diluted plasma was mixed with 10 cc. of chloroform-activated  enzyme, and the mixture 
was then incubated at 37°C.  At intervals, aliquots of 2 cc. of the mixture were removed and 
refrigerated in a salt-water mixture at -10°C.  All  the tubes were thawed simultaneously 
and 2 cc. of 0.3 per cent casein added to each.  The enzyme-inhibitor-substrate  mixtures were 
then incubated at 37°C. for 2 hours, and the amount of substrate digested determined nephelo- 
metrically. This was compared with the proteolytic activity of the same amount of enzyme, 
mixed with buffer instead of the inhibitory plasma. 
The proteolytic activity of the chloroform-activated enzyme was unaffected 
by incubation at 37°C. for 15 minutes before the addition of substrate.  Maxi- 
mal inhibition of this proteolytic activity was observed when the enzyme and 
inhibitor were incubated  together for 10 minutes before the addition  of sub- 
strate (Fig. 3). 
Quantitative study of the inhibition of plasma proteolyfic enzyme requires 
a  knowledge  of the  relationship  between  the  concentration  of inhibitor  and 
the  degree  of inhibition.  Christensen  and  MacLeod  (12)  measured  the  in- 
hibition of chloroform-activated and fibrinolysin-activated plasma proteolytic 
enzyme by an albumin preparation precipitated from pooled serum and purified 
by reprecipitation  and  dialysis  two  times.  They observed  that  the  degree 
of inhibition was directly proportional to the concentration of albumin.  This 
was in contradistinction to the action of pancreatic trypsin inhibitor, in which 
the  inhibition  was  proportional  to  the  logarithm  of  the  concentration 
of inhibitor. 
One cc. of fresh plasma or plasma fraction was diluted serially with buffer.  One cc. of 
each of these dilutions of plasma was added to 2 cc. of pooled chloroform-activated enzyme 
in a Wassermann tube.  At the same time, as a control, i cc. of buffer was added to 2 cc. of 
enzyme.  The enzyme-inhibitor and  enzyme-buffer mixtures were incubated  at 37°C. for 
10 minutes.  A 3 cc. portion of 0.3 per cent casein was then added to each tube, and the 
amount of protein digested during 2 hours at 37°C. measured nephelometrically. 
The data of one such experiment using plasma albumin prepared by precipi- 
tation with ammonium sulfate have been plotted in Fig.  4.  These indicate 
that with the enzyme, inhibitor, and substrate employed, the degree of inhibi- 
tion  of  chloroform-activated  plasma  proteolytic  enzyme  by  fresh  plasma 408  PROTEOLYTIC  ENZYME  IN  HUMAN  PLASMA.  III 
albumin was proportional to the logarithm of the concentration of the albumin. 
In other words, a large change in the concentration of inhibitor led to a rela- 
tively small change  in the inhibition of the enzyme.  The same relationship 
between the concentration of inhibitor and the degree of inhibition was observed 
whether the inhibitory substance tested was fresh whole plasma, fresh serum, 
the  albumin precipitated from fresh plasma  by  ammonium sulfate,  or  the 
supernatant "albumin" fraction which  remained  after the acid precipitation 
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FIG. 3.  The relationship between the proteolytic activity of an enzyme-inhibitor-substrate 
mixture and the duration  of incubation  of enzyme  and inhibitor before the addition  of sub- 
strate. 
of fresh plasma globulin.  Moreover,  this relationship  was found to exist in 
each of  12  patients  tested.  Since the method of  assay and  the  substrate 
employed differed from those employed by  Christensen  and MacLeod, the 
differences  in  result  were  not  necessarily  contradictory.  The  relationship 
between inhibitor concentration and  the degree  of inhibition suggests  that 
inhibitor mad enzyme react in accordance with the law of mass action. 
With this information, the inhibitory activity of the rough albumin fraction 
of fresh plasma of 33 patients, some  of whom had  chronic  hepatic disease, 
was tested against chloroform-activated  enzyme and compared  with the clot 
lysis time determined on these same specimens of plasma. OSCAR D. ~TNO~F  409 
A volume of 2 cc. of plasma was diluted with 38 cc. of water and sut~cient 1 per cent acetic 
acid added to bring the pH to 5.2.  The resultant precipitate was separated by centrifugation 
and 8 cc. of the supematant solution mixed with 2 cc. of buffer.  A 1 cc. aliquot of this rough 
"albumin" fraction was then added to 2 co. of pooled chloroform-activated plasma proteolytic 
enzyme.  Simultaneously, 1 cc. of buffer was added to 2 cc. of the enzyme as a control.  The 
enzyme pool was such that in the final dilution used it would digest approximately  0.50 rag. 
of casein per ce. of enzyme-substrate mixture in 2 hours.  The enzyme-inhibitor and enzyme- 
buffer mixtures were incubated for 10 minutes at 37°C. and 3 cc. of 0.3 per cent casein then 
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FIo, 4. The relationship between the concentration of plasma albumin and its inhibitory 
activity against plasma proteolytic enzyme. 
added to each tube.  The amount of protein  digested at 37°C. during a 2 hour period was 
then determined nephelometrically. 
No  constant  relationship  could  be  demonstrated  between  the  inhibitory 
activity  of the  supematant  "albomln"  against  chloroform-activated plasma 
proteolytic  enzyme and  the  clot  lysis  time  (Fig.  5).  In some experiments, 
the plasma of patients whose clots lysed rapidly was less inhibitory than that 
of normal human beings, but this was not a  constant finding.  Similar studies 
with fresh whole plasma and serum showed no constant relationship between 
inhibitory activity and  the  clot lysis time.  That  is,  the  rate  of fibrinolysis 
could not be correlated adequately with the inhibitory activity of fresh plasma, 
serum, or albumin against plasma proteolytic enzyme. 410  PRO~OL~IC  ~.NZYM~  1~  ~u1KAI~ PLAS~&o  M 
Changes in the fnhibitory  Actidty of Serum during the Incubation  of a 
Recalcified Plasma Clot 
No definite relationship,  then, could be demonstrated between  the rate of 
fibrinolysis of recalcified plasma and the relative available proteolytic activity 
or  inhibitory activity  present  in  plasma.  Several  alternatives  suggested 
I00  " 
>- 
t- 
.~  9o 
V-- 
o 
'~  80 
!-- 
'~  70 
N 
z  60 
h 
o  50 
0 
I11 
Z 
-  30 
w 
~-  20 
o 
L~ 
•  Q 
$ 
N  • 
I  I  l  I  l  ,f  t  I  t 
0~)  I  2  3  4  5  6  7  8  9 
CLOT  LYStS  TIME  IN  DAYS 
Fzo. 5. The relationship between the clot lysis time and the inhibitory activity of fresh 
plasm~ albumin against  plasma  proteolytic enzyme  in 33 patients. 
themselves.  Perhaps caseinolysis was not a measure o~ fibrinolytic activity; 
or, on the other hand, mechanisms might have been involved other than those 
already discussed.  The experiments  next to be described  indicated that the 
latter hypothesis is at least partially valid. 
During the course  of these studies it was observed  that the plasma of a 
patient whose clot lysed rapidly was less inhibitory than normal plasma, when 
the plasmas had been refrigerated  at 4°C. for several days before testing.  In- OSCAR D.P.ATNO~  411 
deed, a rough relationship between clot lysis time and the amount of inhibitor 
in these  stored plasmas  could be demonstrated.  These  data  intimated  that 
rapid fibrinolysis might be due to a  rapid decrease in the inhibitory activity 
of the  serum  during  the  incubation  of the  clot.  The  following experiments 
were designed to test this hypothesis. 
Using sterile technique,  oxalated plasma from one patient was pipetted in 2 cc. amounts 
into each of several Wassermann tubes, and recalc.ified with 0.4 co. of ~.,/20 calcium chloride. 
The tubes were closed with rubber stoppers, and the clots were then incubated at 37°C.  One 
hour later the serum was expressed from the clot in one of the tubes with a sterile wooden 
applicator stick.  This tube was then centrifuged and the serum stored in a sterile lusteroid 
tube in a solid carbon dioxide refrigerator at -70°C.  Each day the serum of another clot 
was separated from its fibrin and stored.  After the clot had lysed, the serum in other tubes 
was stored in the same manner from day to day.  When the entire series had thus been frozen, 
all the tubes were thawed simultaneously and 1 cc. of each specimen was then diluted with 
19 cc. of buffer.  A 1 cc. aliquot of each diluted serum was then added to 2 cc. of chloroform- 
activated enzyme, and the enzyme-iahibitor mixtures were incubated  for 10 minutes.  Then 
an equal volume of 0.3 per cent casein solution was added to each enzyme-inhibitor mixture, 
and the protein digested during incubation at 37°C. for 2 hours was measured nephelometri- 
cally.  These  studies  were performed on the plasmas  of several  patients,  simultaneously, 
usually comparing a known rapid and slow lysing plasma; the clot lysis times were determined 
on aliquots of the same plasmas. 
The data  of several such experiments  have been plotted in Fig.  6.  These 
demonstrated that the inhibitory activity of serum decreased rapidly in patients 
whose clots lysed rapidly, and more slowly in those whose clots lysed slowly. 
In  each  experiment  the  inhibitory  activity  was  approximately  the  same  in 
each  serum  when  lysis  occurred.  Once  fibrinolysis  took place,  virtually  no 
further decrease in inhibitory activity was observed,  although in no case did 
all  inhibitory  activity  disappear.  In  other  words~  the  rate  of  fibrinolysis 
could be related directly to the rate of decrease in inhibitory activity of serum 
when the clot was incubated at 37°C.  It will be noted that in these experiments 
the initial inhibitory activity of the serum of patients whose clots lysed rapidly 
was usually less than that of patients whose clots lysed slowly.  This had not 
been  observed  when  fresh  plasma  was  tested,  and  may indicate  that  some 
deterioration  of  inhibitory  activity  occurred  during  storage  in  the  carbon 
dioxide refrigerator. 
The nature  of the decrease  in inhibitory  activity was  investigated  but re- 
mained  obscure.  The  effect  of the  fibrin  clot  itself  or  calcium  was  tested. 
Oxalated  plasma  was  incubated  at  37°C.  without  recalcification,  and  1  cc. 
portions  were  removed  at  intervals  and  stored  at  --70°C.  These  aliquots 
were  thawed  simultaneously  and  their  inhibitory  activity  determined  as  in 
the previous experiment.  Again the clot lysis time could be correlated  with 
the decrease in inhibitory activity of tlhe plasma.  In other experiments,  the 
oxalated  plasma  was  clotted  by  recalcification.  One  hour  later  the  serum 412  PROTEOLYTIC  ENZYM~  IN HUMAN  PLASMA. 
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FIo. 6. Changes in the inhibitory  activity  of serum during its incubation at 37°C., as 
demonstrated in the sera of 12 patients. Sterile  plasma of each patient was pipctted into 
several Wassermann tubes and recalcified. The clots  which formed were then incubated 
at  37°C.  At various  intervals  serum was  expressed  from succeeding tubes  and  frozen,  When 
all  the  sere  had been  frozen  in  this  manner, they  were  thawed simultaneously.  The inhibitory 
activities  of the sere of 2 patients  were then determined together for comparison.  In the 
figure  the inhibitory  activity  of the serum is  recorded as the inverse  of the amount of sub- 
strate digested. The arrows indicate  the time at which the recalcified  plasma clot  lysed; 
where  no arrow  is  present,  clot  lysis  did  not  occur during the period  of  observation.  See text. 
was separated from the clot and incubated at 37°C.  AHquots of this serum 
were removed at intervals and refrigerated at --70°C.  The sera were thawed 
simultaneously, and their inhibitory activities determined.  In each case the 
inhibitory activity of the serum decreased during the period of incubation, 
and  fibrinolysis occurred when  the  inhibitory activity reached a  minimum. OSCAR D.  RATNOF~  413 
These studies  demonstrated that  the  decrease in inhibitory activity during 
the incubation of a  recalcified plasma clot at 37°C.  did not depend upon the 
presence of calcium or fibrin.  Furthermore,  the proteolytic activity of the 
diluted serum or plasma,  tested upon the same concentration of casein but 
with the  substitution of buffer for  chloroform-activated enzyme,  was  zero. 
Therefore, the changes observed could be attributed to a decrease ininhibitory 
activity rather than a simultaneous increase in the spontaneous plasma proteo- 
lyric activity. 
The decrease in inhibitory activity was due to a change in the rough albtlmln 
fraction.  Plasma  was  incubated  at  37°C.  and  aliquots  were  refrigerated 
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FIG. 7. Changes in the inhibitory  activity  of  the serum albumin during the incubation  at 
37°C. of  sera  from patients  Z and H.  See text. 
from time to time as in the earlier experiments.  The aliquots were thawed 
simultaneously, diluted with 19 volumes of water, acidified to pH 5.2, and the 
globulin precipitate removed by centrifugation.  The supernatant "album~n" 
solutions were diluted with half a  volume of buffer, to neutralize the acetic 
acid.  The inhibitory activity of these "albumin" fractions, like that of whole 
plasma, decreased during the course of incubation at 37°C. (Fig. 7). 
In summary, then, the clot lysis time was correlated with the decrease in 
~nhibitory activity against  chloroform-activated plasma  proteolytic enzyme 
which occurred during the course of incubation of plasma or serum at 37°C. 
In those patients whose clots lysed rapidly, the inhibitory activity of the plasma, 
serum, or albumin reached a  minimum more rapidly than normally.  After 
clot lysis had occurred, there was little or no further decrease in the amount 
of inhibitor present, although inhibitory activity was not completely abolished. 
The phenomenon was unrelated to the presence of calcium or fibrin. 414  PROTEOLYTIC  ENZYME  IN  ti~AM.AI~ PLASMA.  III 
DISCUSSION 
The experiments which have been described hint  at possible explanations 
for  the  phenomenon  of  rapid  fibrinolysis  occasionally  observed  in  human 
plasma.  The clot lysis time could not be correlated with the total available 
proteolytic activity which resides  in plasma globulin,  at least as measured by 
the several techniques used.  On the other hand, no relationship was demon- 
strated between the clot lysis time and the ability of fresh plasma to inhibit 
plasma proteolytic enzyme.  However, when recalcified plasma was incubated 
at 37°C., its inhibitory activity against plasma proteolytic enzyme gradually 
decreased until a relatively stationary minimum was reached.  This occurred 
at approximately the time that the clot lysed.  In any given experiment, the 
minimal level of activity of several plasmas was approximately the same,  but 
the  rate  at  which  this  minimal  level  was  reached  varied  with  the  rate 
of fibrinolysis. 
No attempt was made to  correlate rapid  fibrinolysis  with  the  amount  of 
fibrinogen  in  these plasmas.  However,  Geill  (14)  and  others have  demon- 
strated  that  the concentration  of fibrinogen  in  the  plasma of  patients with 
all but the most catastrophic liver disease is either normal or slightly elevated. 
Consequently, it seems unlikely that  a  decrease in available  substrate  is  a 
common concomitant of rapid fibrinolysis. 
The nature of the decrease in the inhibitory activity of plasma is not clear. 
This is due in part to a dearth of information concerning  the chemical composi- 
tion of the inhibitory substance or substances.  It was apparently not depend- 
ent  upon the presence of calcium or fibrin.  A similar phenomenon was de- 
scribed by Jobling and Petersen (13) in 1914, but they did not relate it to clot 
lysis.  These authors  reported  that  the  trypsin-inhibiting  activity of serum 
decreased 5 to  10 per cent during  the first few days of incubation and then 
remained constant indefinitely. 
Perhaps the inhibitory activity of plasma depends upon a mixture of labile 
and stable components.  The labile component deteriorates during the incuba- 
tion of the clot at 37°C.  Thus far, attempts to define the nature of this deteri- 
oration have not been illuminating.  Certain preliminary observations suggest 
that oxidation may be one of the ways that labile inhibitor is destroyed.  It 
was  observed that  clot lysis was  always more  rapid  in Wassermann  tubes 
which  were  plugged  with  cotton compared  with  those  closed with  rubber 
stoppers;  but ready access to oxygen was not the only variable in such ex- 
periments.  Furthermore,  mild oxidants were shown to speed clot lysis, but 
the data are sufficiently equivocal not to permit any definite conclusions.  It 
is of interest  that  the  inhibitory activity of plasma was recently found  by 
Grob (15)  to be diminished in the presence of oxidants.  Moreover, he ob- 
served that reconstituted proteins, prepared from the purified plasma protein 
fractions of Cohn and his associates, had only a small fraction of the inhibitory OSCAR D.  ~XNOYF  415 
activity of fresh serum or plasma  against plasma proteolytic enzyme, when 
tested by methods similar to those reported here.  In the present study, similar 
observations were made upon individual protein fractions?  This suggests 
that the labile inhibitor may not be precipitated with the proteins or may have 
been destroyed during the fractionation process. 
Finally, several  alternative hypotheses might explain  the  mechanism of 
deterioration  of  the  labile  inhibitor  of  plasma proteolytic  enzyme.  Con- 
ceivably, there may be an enzyme in plasma which destroys the labile inhibitor, 
and such an enzyme may be present in excess in patients with short clot lysis 
times.  Or the labile inhibitor of patients with short clot lysis times may be 
qualitatively more susceptible  to deterioration than that of normal human 
beings.  Or some substance or substances  present in normal plasma may be 
capable  of slowing the deterioration of labile inhibitor, and these substances 
may be lacking in the patient with rapid fibrinolysis.  These various hypotheses 
are now the subjects of further investigation. 
SUMM~LRy 
Methods are described for the assay of chloroform-activated  and fibrinolysin- 
activated plasma proteolytic enzyme, and for the determination of the inhibi- 
tory  activity  of  plasma  or  other  substances  against  chloroform-activated 
enzyme. 
The  inhibitory activities  of  plasma,  serum,  and  crude  plasma  albumin 
against  chloroform-activated plasma  proteolytic enzyme were  proportional 
to  the  logarithm  of  the  concentration of  the  inhibitory substance  tested. 
This suggests that enzyme and inhibitor react in accordance  with the law of 
mass action. 
The rate of fibrinolysis of recalcified plasma clots could not be related to the 
total proteolytic activity available in the plasma, nor to the inhibitory activity 
of fresh plasma or serum against plasma proteolytic enzyme. 
During the incubation of a recalcified plasma clot at 37°C., the inhibitory 
activity of its  serum  against plasma proteolytic enzyme decreased  until a 
minimal stationary level was reached.  The clot lysis time could be correlated 
directly with the time which elapsed until this minimal level was reached. 
It is a  pleasure to acknowledge the advice and encouragement of Dr. George S. Mirick. 
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